Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Head & Neck 2Dermatologic 1

Conditions

Breast Neoplasms 2400Neoplasms 1819Carcinoma, Non-Small-Cell Lung 1599Prostatic Neoplasms 1298Colorectal Neoplasms 1140Lung Neoplasms 984Neoplasm Metastasis 830Multiple Myeloma 792Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 586Carcinoma, Hepatocellular 567Recurrence 562Brain Neoplasms 527Glioblastoma 513Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 465Lymphoma 454Uterine Cervical Neoplasms 450Carcinoma, Renal Cell 425Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 389Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 352

Interventions

pembrolizumab 1Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Leukoplakia × 1 year × Clear all
NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

University of Southern California

Phase 1/2 Recruiting
20 enrolled
DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal

NCT03603223 2025-07-30

Pembrolizumab in Treating Participants With Leukoplakia

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
26 enrolled
Head & Neck

Leukoplakia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡